Reports that the pharmaceutical industry is still having problems with the European Union (EU) rules on the protection of personal data. Privacy of data transmitted between the EU and the United States; Provisions of the United States Commerce Department's `international safe harbor privacy principles'; Comments from the Pharmaceutical Research and Manufacturers of America.